The role of inflammasomes in multiple sclerosis.

Multiple Sclerosis : Clinical and Laboratory Research
Hanie Yavarpour-Bali, Maryam Ghasemi-Kasman

Abstract

Multiple sclerosis (MS) is considered as an inflammatory autoimmune disease of the central nervous system (CNS), with a complex and heterogenic etiology. However, the involvement of inflammation in its pathophysiology is well documented and current therapies for MS are mainly immunosuppressive drugs. Although the available drugs reduce new lesions and relapses, their long-term outcome is not completely satisfactory. Inflammasomes are multimeric protein complexes that play a critical role in the inflammatory process. Several lines of evidence suggest an association between inflammasome activation and MS. In this paper, we have reviewed current studies that demonstrate the involvement of inflammasomes in MS development, in both animal model and MS patients. Furthermore, prior studies about the effect of inflammasome inhibitor drugs on development and progression of MS are discussed.

References

May 9, 2002·Journal of the Neurological Sciences·Xue MingPeter C Dowling
Nov 27, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Athena M SoulikaDavid Pleasure
Jun 25, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Denis GrisJenny P-Y Ting
Nov 26, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Sushmita JhaJenny P-Y Ting
Feb 26, 2011·Nature Reviews. Immunology·Mohamed Lamkanfi
Oct 18, 2011·Nature·Nobuhiko KayagakiVishva M Dixit
Jun 16, 2012·Proceedings of the National Academy of Sciences of the United States of America·Makoto InoueMari L Shinohara
Jul 26, 2013·PloS One·Sarah E LutzEliana Scemes
Jan 16, 2014·Autoimmunity Reviews·Ron Milo, Ariel Miller
Jul 26, 2014·International Journal of MS Care·Bonnie I GlanzBrian C Healy
Jan 15, 2015·Brain : a Journal of Neurology·Sunny MalhotraManuel Comabella
Apr 17, 2015·Immunological Reviews·Si Ming Man, Thirumala-Devi Kanneganti
Jun 30, 2015·Nature Medicine·Haitao GuoJenny P-Y Ting
Jul 16, 2015·European Journal of Immunology·Paul J BakerSeth L Masters
Apr 3, 2016·Immunity·Moritz M GaidtVeit Hornung
Dec 17, 2016·Current Pharmaceutical Design·Ivana BjelobabaIrena Lavrnja
Jan 28, 2017·Journal of Tissue Engineering and Regenerative Medicine·Maryam Ghasemi-KasmanMohammad Javan
May 23, 2017·International Immunology·Sannula Kesavardhana, Thirumala-Devi Kanneganti
Nov 10, 2017·Multiple Sclerosis : Clinical and Laboratory Research·Sunny MalhotraManuel Comabella
Feb 7, 2018·Frontiers in Immunology·Marjan GharagozlooDenis Gris
Apr 5, 2018·Frontiers in Neurology·Robert W KeaneJuan Pablo de Rivero Vaccari
Apr 12, 2018·Expert Opinion on Emerging Drugs·Ram Narendra NarayanOlaf Stüve
Jun 14, 2018·Proceedings of the National Academy of Sciences of the United States of America·Brienne A McKenzieChristopher Power
Jan 19, 2019·Multiple Sclerosis and Related Disorders·Jaine Ls SoaresAlessandra Pontillo
Jul 3, 2019·Cellular Microbiology·Nathaniel WinsorStephen E Girardin
Aug 1, 2019·Biomedicines·Gabrielle Macaron, Daniel Ontaneda
Sep 6, 2019·Life Sciences·Sahar Rostami MansoorMaryam Ghasemi-Kasman
Apr 14, 2020·Brain : a Journal of Neurology·Sunny MalhotraManuel Comabella

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

© 2022 Meta ULC. All rights reserved